Date: Wednesday 24 May
Time: 17:00 - 18:00
Venue: Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE
One of a series of lectures organised by the Cambridge Biomedical Research Centre.
Professor Nadeem Sarwar's expertise stems from the intersection of innovation in human genetics and drug discovery with collaborative business models to accelerate delivery of novel, targeted therapeutics. He is Founder and President of the Eisai AiM Institute, an industry unique discovery innovation unit exclusively focused on realizing human genetics guided drug discovery and precision medicine. He has senior-level experience within academia (tenured faculty, University of Cambridge), big-pharma (Senior Director, Pfizer), medium-sized pharma (Vice President, Eisai), and Biotech-like organizations (President, Eisai AiM Institute).
